Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (231-240 of 272) with videos related to

Pageof 28
Sort By:
AIDS (London, England)|July 11, 2017
Selection of women at risk for cervical cancer in an HIV-infected South African populationMarjolein Van Zummeren, Wieke W Kremer, Matthys C Van Aardt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2018
HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesionsMarjolein van Zummeren, Wieke W Kremer, Annemiek Leeman, et al.
The Lancet. Oncology|January 20, 2019
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trialNicole J Polman, Renée M F Ebisch, Daniëlle A M Heideman, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based ApproachJamie J Beagan, Esther E E Drees, Phylicia Stathi, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Gynecologic Oncology|February 11, 2015
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapesViola M J Verhoef, Folkert J van Kemenade, Lawrence Rozendaal, et al.
International Journal of Cancer|June 14, 2014
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screeningRemko P Bosgraaf, Viola M J Verhoef, Leon F A G Massuger, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal of Clinical Pathology|August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 yearsA Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
Cancer Discovery|February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancerElza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
Pageof 28

Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
AIDS (London, England)|July 11, 2017
Selection of women at risk for cervical cancer in an HIV-infected South African populationMarjolein Van Zummeren, Wieke W Kremer, Matthys C Van Aardt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2018
HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesionsMarjolein van Zummeren, Wieke W Kremer, Annemiek Leeman, et al.
The Lancet. Oncology|January 20, 2019
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trialNicole J Polman, Renée M F Ebisch, Daniëlle A M Heideman, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based ApproachJamie J Beagan, Esther E E Drees, Phylicia Stathi, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Gynecologic Oncology|February 11, 2015
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapesViola M J Verhoef, Folkert J van Kemenade, Lawrence Rozendaal, et al.
International Journal of Cancer|June 14, 2014
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screeningRemko P Bosgraaf, Viola M J Verhoef, Leon F A G Massuger, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal of Clinical Pathology|August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 yearsA Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
Cancer Discovery|February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancerElza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
Pageof 28